Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ipratropium in Depression-related Pediatric Asthma
NCT04617015Phase 1Completed
- Sponsor
- University at Buffalo
- Start
- Sep 2016
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ipratropium bromide in asthma, sponsored by University at Buffalo. Primary endpoint: Forced Expiratory Volume in 1 second Percent Change Post-ipratropium at 30 minutes. Started Sep 2016; status: completed.
02
Drugs
ipratropium bromide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT04617015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04617015.